Cargando…
Frequent loss of metastatic ability in subclones of Apc, Kras, Tgfbr2, and Trp53 mutant intestinal tumor organoids
Cancer evolution is explained by the accumulation of driver mutations and subsequent positive selection by acquired growth advantages, like Darwin's evolution theory. However, whether the negative selection of cells that have lost malignant properties contributes to cancer progression has not y...
Autores principales: | Morita, Atsuya, Nakayama, Mizuho, Wang, Dong, Murakami, Kazuhiro, Oshima, Masanobu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067385/ https://www.ncbi.nlm.nih.gov/pubmed/36576236 http://dx.doi.org/10.1111/cas.15709 |
Ejemplares similares
-
Malignant subclone drives metastasis of genetically and phenotypically heterogenous cell clusters through fibrotic niche generation
por: Kok, Sau Yee, et al.
Publicado: (2021) -
Genetic and nongenetic mechanisms for colorectal cancer evolution
por: Kok, Sau Yee, et al.
Publicado: (2023) -
Genetic Alterations and Microenvironment that Drive Malignant Progression of Colorectal Cancer: Lessons from Mouse and Organoid Models
por: Nakayama, Mizuho, et al.
Publicado: (2022) -
Mutant p53 in colon cancer
por: Nakayama, Mizuho, et al.
Publicado: (2018) -
Subclonal TP53 mutations are frequent and predict resistance to radioimmunotherapy in follicular lymphoma
por: Burack, W. Richard, et al.
Publicado: (2023)